Could DIZE be the answer to COVID-19?

Maturitas. 2020 Oct:140:83-84. doi: 10.1016/j.maturitas.2020.07.002. Epub 2020 Jul 2.

Authors

Tawar Qaradakhi¹, Laura Gadanec¹, John Matsoukas², Vasso Apostolopoulos³, Anthony Zulli⁴

Affiliations

¹ Institute for Health and Sport, Victoria University, Melbourne, VIC, Australia.
² NewDrug S.A., Patras Science Park, Patras, Greece.
³ Institute for Health and Sport, Victoria University, Melbourne, VIC, Australia. Electronic address: vasso.apostolopoulos@vu.edu.au.
⁴ Institute for Health and Sport, Victoria University, Melbourne, VIC, Australia. Electronic address: anthony.zulli@vu.edu.au.

No abstract available

Keywords: ACE2; COVID-19; Coronavirus; DIZE; Diminazene aceturate; SARS-CoV-2.

Publication types

Editorial
Comment

MeSH terms

Angiotensins
Betacoronavirus
COVID-19
Coronavirus Infections*
Diminazene / analogs & derivatives
Humans
Pandemics*
Peptidyl-Dipeptidase A*
Pneumonia, Viral*
SARS-CoV-2

Substances

Angiotensins
Peptidyl-Dipeptidase A
diminazene aceturate
Diminazene